Shares of Lantheus Holdings, Inc. LNTH fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.
Lantheus Holdings shares dipped 22.5% to $58.93 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Invivyd, Inc. IVVD shares surged 170% to $4.40 after the company reported positive initial results from ongoing CANOPY Phase 3 pivotal clinical trial investigating VYD222 for the Prevention of COVID-19.
- Cuentas Inc. CUEN shares climbed 71.6% to $2.37.
- iCoreConnect Inc. ICCT shares jumped 49.4% to $2.54 after surging over 73% on Friday.
- ZimVie Inc. ZIMV gained 42.8% to $16.03 after the company disclosed an agreement to sell its spine business to H.I.G. Capital for $375 million.
- Biomerica, Inc. BMRA climbed 42.4% to $1.41. Biomerica received FDA 510(k) clearance for its Hp Detect Stool Antigen ELISA test, designed to detect the presence of the H. pylori bacteria.
- Akso Health Group AHG gained 41.6% to $0.8499.
- Energy Services of America Corporation ESOA surged 35.4% to $4.7399 following FY23 earnings results.
- LQR House Inc. LQR gained 30.9% to $3.3649.
- United States Steel Corporation X rose 26.5% to $49.77 after Nippon Steel announced it will acquire the company for $55 per share in an all-cash transaction.
- Color Star Technology Co., Ltd. ADD climbed 26.5% to $0.50.
- ZK International Group Co., Ltd. ZKIN rose 22.3% to $1.26.
- Wheeler Real Estate Investment Trust, Inc. WHLR shares gained 22.2% to $0.2750 after dipping around 24% on Friday.
- Arcutis Biotherapeutics, Inc. ARQT gained 21.3% to $2.96 after the FDA approved the company's Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older.
- Cadrenal Therapeutics, Inc. CVKD climbed 20.5% to $0.6143. Noble Capital Markets initiated coverage on Cadrenal Therapeutics with an Outperform rating and announced a price target of $4.
- Alaunos Therapeutics, Inc. TCRT shares rose 18% to $0.0537 after declining 11% on Friday.
- Ideal Power Inc. IPWR gained 16.7% to $9.06.
- NightHawk Biosciences, Inc. NHWK gained 14% to $0.43 as the company announced major milestone with completion of manufacturing run for a premier U.S.-based biopharmaceutical company.
- James River Group Holdings, Ltd. JRVR gained 12.8% to $9.58.
- B. Riley Financial, Inc. RILY rose 10.8% to $22.66.
- Sonoma Pharmaceuticals, Inc. SNOA shares surged 10.4% to $0.16 after falling over 6% on Friday.
- Ontrak, Inc. OTRK rose 9.6% to $0.45 after falling over 8% on Friday.
- Cleveland-Cliffs Inc. CLF gained 8.7% to $20.33 after the company issued a statement regarding the proposed acquisition of U.S. Steel by Nippon Steel.
- Super Micro Computer, Inc. SMCI rose 7.3% to $321.98.
Losers
- Ebix, Inc. EBIX shares fell 70.6% to $1.45 after the company and certain US affiliates filed for protection under Chapter 11 and reached a stalking horse agreement to sell its North American Life and Annuity assets to Zinnia.
- Jin Medical International Ltd. ZJYL dipped 52.1% to $13.43.
- Cara Therapeutics, Inc. CARA declined 51.1% to $0.6010 as the company announced outcome from dose-finding Part A of KIND 1 study evaluating oral difelikefalin for moderate-to-severe pruritus in patients with atopic dermatitis.
- Checkpoint Therapeutics, Inc. CKPT shares fell 48.5% to $1.7090. The FDA has issued a Complete Response letter to Checkpoint Therapeutics' Cosibelimab Biologic License Application for metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.
- Structure Therapeutics Inc. GPCR fell 47.1% to $31.27 after the company announced a comprehensive development program update for GSBR-1290.
- Near Intelligence, Inc. NIR shares fell 43.9% to $0.0331 after dipping 20% on Friday.
- Minerva Surgical, Inc. UTRS shares fell 38.3% to $1.7375. On Dec. 15, 2023, Minerva Surgical notified the Nasdaq of its intent to file a Form 25 with the SEC on or about Dec. 26, 2023 to effect the voluntary delisting of the company's common stock from Nasdaq.
- Maison Solutions Inc. MSS shares fell 38% to $1.55 after dipping 83% on Friday.
- SunPower Corporation SPWR fell 35% to $3.9899 after the company said substantial doubt exists about its ability to continue as a going concern.
- PureCycle Technologies, Inc. PCT declined 34.3% to $3.2563 after the company issued Ironton
- operations update.
- Fortress Biotech, Inc. FBIO fell 22.8% to $2.37.
- Shengfeng Development Limited SFWL dipped 22.2% to $7.72.
- Gossamer Bio, Inc. GOSS fell 22.2% to $0.7938.
- Conduit Pharmaceuticals Inc. CDT declined 21.5% to $5.54.
- Gaotu Techedu Inc GOTU fell 19.6% to $3.7250.
- Know Labs, Inc. KNW declined 19% to $0.6788.
- Maxeon Solar Technologies, Ltd. MAXN fell 19% to $4.9820. Goldman Sachs maintained Maxeon Solar Technologies with a Buy and lowered the price target from $18 to $11.
- Mirum Pharmaceuticals, Inc. MIRM fell 19% to $28.31 after announcing data from EMBARK Phase 2b study for biliary atresia.
- Masonite International Corporation DOOR fell 14.8% to $86.88 after the company announced the acquisition of PGT Innovations.
- Ainos, Inc. AIMD fell 13.5% to $2.87 after jumping 31% on Friday.
- bluebird bio, Inc. BLUE dipped 11% to $2.91.
- LG Display Co., Ltd. LPL fell 10.6% to $4.3510.
- Lufax Holding Ltd LU declined 10% to $3.1950. Lufax Holding announced that it received a letter from the NYSE dated notifying the company that it is below the NYSE's Continued Listing Standards.
- Northann Corp. NCL shares fell 9.3% to $14.44 after surging 42% on Friday.
- Chavant Capital Acquisition Corp. CLAY shares fell 9.2% to $9.53 after gaining 5% on Friday.
- V.F. Corporation VFC fell 7.7% to $18.38. VF Corp said on Dec. 13, it detected unauthorized occurrences on a portion of its IT systems.
- Sunrun Inc. RUN fell 6.2% to $17.48. Goldman Sachs maintained Sunrun with a Buy and raised the price target from $17 to $20.
Now Read This: Ethereum Falls Below $2,200; Celestia, SATS Among Top Losers
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.